Estrella Immunopharma, Inc. (ESLA)

Estrella Immunopharma Statistics

Total Valuation

ESLA has a market cap or net worth of $27.49 million. The enterprise value is $32.72 million.

Market Cap	27.49M
Enterprise Value	32.72M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, before market open.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

ESLA has 36.17 million shares outstanding. The number of shares has increased by 255.55% in one year.

Current Share Class	36.17M
Shares Outstanding	36.17M
Shares Change (YoY)	+255.55%
Shares Change (QoQ)	-0.87%
Owned by Insiders (%)	2.70%
Owned by Institutions (%)	0.81%
Float	9.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	233.44
P/TBV Ratio	234.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.55

Current Ratio	0.55
Quick Ratio	0.31
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-6,160.07%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ESLA has paid $126 in taxes.

Income Tax	126
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.86% in the last 52 weeks. The beta is 0.40, so ESLA's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-26.86%
50-Day Moving Average	1.08
200-Day Moving Average	1.12
Relative Strength Index (RSI)	41.83
Average Volume (20 Days)	39,534

Short Selling Information

The latest short interest is 22,554, so 0.06% of the outstanding shares have been sold short.

Short Interest	22,554
Short Previous Month	21,981
Short % of Shares Out	0.06%
Short % of Float	0.23%
Short Ratio (days to cover)	0.93

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.85M
Pretax Income	-6.09M
Net Income	-8.85M
EBITDA	n/a
EBIT	-8.85M
Earnings Per Share (EPS)	-$0.24

Balance Sheet

The company has $916,916 in cash and n/a in debt, giving a net cash position of $916,916 or $0.03 per share.

Cash & Cash Equivalents	916,916
Total Debt	n/a
Net Cash	916,916
Net Cash Per Share	$0.03
Equity (Book Value)	143,731
Book Value Per Share	0.00
Working Capital	-1.36M

Cash Flow

Operating Cash Flow	-6.23M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ESLA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-255.55%
Shareholder Yield	-255.55%
Earnings Yield	-26.32%
FCF Yield	n/a

Analyst Forecast

The average price target for ESLA is $16.00, which is 2,005.26% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.00
Price Target Difference	2,005.26%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	38.11%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1